Benefits of 1000 bottles of red wine could come from pill

   Feb 5, 11:57 am

Washington, Feb 5 (ANI): Lovers of red wine were delighted when it was found to contain resveratrol - a compound supposed to improve health and maybe even lengthen life.

But studies have insisted that to see benefits, you would need to consume large amounts of the compound - more than is found in a bottle of wine.

Now a new study suggests we could get the equivalent of large resveratrol doses from pills we already have- a class of drugs that are being tested for use as treatments for Alzheimer's and Parkinson's disease.

The findings suggest these drugs, known as known as phosphodiesterase type 4 (PDE4) inhibitors, may provide a practical way to reap red wine's benefits than consuming buckets of the stuff (which would certainly carry health risks).

"[The study] reveals a novel utility for this class of drugs that hasn't been explored before," said study researcher Dr. Jay H. Chung, chief of the Laboratory of Obesity and Aging Research at the National Heart, Lung, and Blood Institute.

However, the study was conducted in mice, and the results will need to be replicated in people.

In the study, scientists aimed to figure out exactly how resveratrol, a compound in red wine, acts inside cells. They discovered resveratrol works in a different manner than previously thought.

The study showed that resveratrol inhibits a protein known as phosphodiesterase type 4 (PDE4). That meant that resveratrol is a PDE4 inhibitor.

Knowing that drugs called PDE4 inhibitors werebeing tested to treat Alzheimer's, the researchers gave one such drug, called rolipram, to mice.

They found the drug produced all the health benefits of resveratrol, including preventing diet-induced obesity and improving control over blood sugar levels.

In studies on people, resveratrol has been shown to have anti-diabetes effects. But people would need to consume about 1,000 bottles of red wine a day in order to take in enough resveratrol to see true health benefits, Chung said.

PDE4 inhibitors could provide a realistic way for people to get the same benefits, the researchers said. In addition, PDE4 inhibitors may be less toxic than resveratrol itself, because the compound interacts with many proteins inside cells.

"By just targeting the key player [PDE4] you minimize the potential for adverse effects," Chung added.

Chung said he is planning to conduct a follow-up study that examines the effects of rolipram on obese people with insulin resistant.

The study has been published in the journal Cell. (ANI)

Bitter compounds in cucumber may help treat cancer, diabetes Nov 28, 2:19 pm
Washington, Nov 28 (ANI): A new study has found that the compounds in responsible for the bitter taste in cucumbers may be able to treat cancer and diabetes.
Full Story
First time in India, Kerala hospital performs rare treatment for acute blood cancer Nov 27, 11:19 am
Kochi, Nov.27 (ANI): Nineteen-year-old Neena (name changed) was suffering from acute blood cancer or acute myeloid leukaemia. Her disease slipped into a life-threatening stage even after two cycles of chemotherapy. She did not have a human leukocyte antigen, or HLA matched related or unrelated donor for a stem cell transplant, the standard procedure for such medical situations.
Full Story
Drinking 3-5 cups of coffee may reduce Alzheimer's risk by 20pc Nov 27, 10:51 am
Washington, Nov 27 (ANI): A new study has demonstrated that drinking 3-5 cups of coffee might help in lowering the risk of Alzheimer's disease by up to 20 percent.
Full Story
Thanksgiving day turkeys can also be 'lifesavers' Nov 26, 2:45 pm
Washington, Nov 26 (ANI): Turkey, which popularly makes the festive thanksgiving meal, is not only good in taste, but can also save your life, says a new study.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY